Announcements Trials

Browse Landscape

Phase

Status

Completed 5 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 9 Recurrence 1 Oligodendroglioma 1 Neoplasms 1 Neoplasm Recurrence, Local 1 Medulloblastoma 1 Lymphoma, Large B-Cell, Diffuse 1 Glioma 1 Central Nervous System Neoplasms 1 Burkitt Lymphoma 1 Brain Neoplasms 1 Astrocytoma 1

Interventions

Temozolomide 5 Radiotherapy 5 Bevacizumab 2 trametinib 1 tislelizumab 1 olutasidenib 1 mirdametinib 1 dabrafenib 1 abexinostat 1 Vincristine 1 Tretinoin 1 Radiation 1 Procarbazine 1 ONC206 1 Lomustine 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Diphtheria-Tetanus Vaccine 1 Cetuximab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Oligodendroglioma × Lomustine × Clear all

NCT05331521 2026-02-03

ImproveCodel

University Hospital Heidelberg

Phase 3 Recruiting

Oligodendroglioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡